A B S T R A C T Random migration of human platelets has been recognized as a parameter of platelet function which can be assessed in a reproducible manner by modification of the Boyden micropore filter technique for evaluating this function in other cells (Boyden, S. 1962. J. Exp. Med. 115: 453-466). Because platelets are extremely susceptible to aggregation, the conditions for collecting and isolating platelets and the migration buffer (Ca"+ and Mg"+-free phosphate buffered saline, pH 6.8, with glucose and gelatin) were selected to minimize such a possibility. The random movement of platelets into the micropore filter was maximal at 30-37°C and was contingent upon the metabolic integrity of the cell; thus, it can be attributed to active spontaneous migration. While the initiating and enhancing effects of epinephrine on the platelet aggregation-release reaction are mediated by an a-adrenergic receptor, the inhibition of random migration involved a P-receptor. Equimolar propranolol but not phentolamine prevented epinephrine inhibition of random migration, and isoproterenol had activity comparable to epinephrine while phenylephrine was inactive. The capacity of the cholinomimetic agent, carbachol, to increase platelet migration is reminiscent of the recent findings in several cell systems in which P-adrenergic and cholinergic stimuli have opposite effects. The prostaglandins E1 and E2 augmented spontaneous migration in contrast to their well established inhibitory action on platelet aggregation at the concentrations employed. The suppression by indomethacin of prostaglandin enhancement and of spontaneous migration implies a requirement for the prostaglandin biosynthetic pathway during the migration process. Thus, the spontaneous migration of human platelets, an additional parameter of platelet function for in vitro investigations, disclosed not only a 1-adrenergic receptor for epinephrine, but also a capacity for Mr.
INTRODUCTION
The methods for in vitro assessment of human platelet function have included platelet adherence to synthetic surfaces, aggregation as measured by changes in the optical density of platelet suspensions, and release of specific platelet constituents induced by aggregating agents (1, 2) but have not included directed or random migration. The coincidental observation that platelets as well as polymorphonuclear and mononuclear leukocytes moved through a micropore filter during studies of random migration of mixed leukocyte populations prompted a specific investigation of platelet migration. The Boyden chamber method (3) for studying spontaneous and directed migration of various classes of leukocytes was adapted for such platelet studies by appropriate selection of pore size, buffer, and other conditions. This in turn permitted analysis of the effects of adrenergic and cholinergic stimuli and prostaglandins on spontaneous migration of human platelets. METHODS Polystyrene disposable chemotactic chambers (Adaps Inc., Dedham, Mass.) and micropore filters (Millipore Corp., Bedford, Mass.) were assembled as previously described (4) . L-epinephrine (Sigma Chemical Co., St. Louis, Mo.), phentolamine (Regitine, Ciba Pharmaceutical Company, Summit, N. J.), propranolol (Inderal, Ayerst Laboratories, New York), gelatin (Difco Laboratories, Detroit, Mich.), and prostaglandins PGE1, PGE2, and PGFft (The Upjohn Co., Kalamazoo, Mich.) were obtained as noted. Siliconized (Dricote, Fisher Scientific Co., Fair Lawn, N. J.) glassware and needles or plastic materials were used for all platelet suspensions.
Platelet isolation. Fresh human blood was collected from normal volunteers who had taken no drugs known to affect platelet function for at least 5 days before venipuncture. 5-ml portions of blood were mixed with 1 ml of sodium citrate anticoagulant (citric acid 0.076 M, sodium citrate 0.15 M, pH 5.2) in 14-ml plastic tubes and were immediately centrifuged at 200 g for 15 min at room temperature. The platelet-rich plasma was removed from the buffy coat and red cell infranate and was centrifuged at 900 g for 20 min. The platelet-poor supernate was discarded, and the platelet pellet was resuspended by repeated gentle aspiration with a pipette in the standard buffered medium (pH 6.8, 0.005 M KH2PO4, 0.005 M Na2HPO,, 0.1 M NaCl, 0.2 g/100 ml glucose, and 0.5 g/100 ml gelatin). Platelet counts were performed by phase-contrast microscopy.
Platelet migration. 0.5 ml of platelet suspension containing 4-6 X 107 platelets and less than 0.1% leukocytes was added to the cell compartment of a modified Boyden chamber which was separated from the medium compartment below by an 8-Am micropore filter. After a 3-h incubation at 370C, the filters were washed twice in 0.15 M NaCl, fixed in 10% (vol/vol) formalin (5) containing 0.15 M sodium acetate (pH 7.2) for 1 h, stained with Harris' hematoxylin (5) and mounted on glass slides. All experiments were performed in duplicate or triplicate. Migration into each filter was quantitated by counting the number of platelets in 10 high-power fields (HPF) 1 at a fixed level for each experiment of 40-70 ,Am from the source of the platelets at the top of the filter. The microscope slides containing the mounted micropore filters were coded and counted in blind fashion by two investigators. The variation in interpretation was less than 20% of the mean of the separate readings. Modifications of the medium composition or agents tested for their effect on platelet migration were present on both the platelet and medium sides of the filter with no concentration gradient. Statistical analysis of data was performed with a standard paired t test.
RESULTS
Determination of the optimal conditions for migration The influence of buffer composition, filter pore size, and conditions of incubation on the rate of migration of platelets was assessed by counting triplicate filters at hourly intervals up to 5 h for each set of conditions.
The time-course of migration for platelets suspended in the standard buffered medium and incubated at 370C always revealed a continuous increase of platelet counts as the duration of incubation increased. After 3 h of incubation, platelet counts per HPF 50 Am from the platelet layer at the top of the micropore filter in a typical experiment were 3-5 for 3 sum, 9-13 for 5 Am, and 19-25 for 8 Am pore size. In all subsequent experiments platelets were incubated for 3 h on 8-/m millipore filters and counted at a fixed depth from 40 to 70 Am for each experiment.
Platelet migration was maximal at temperatures between 30 and 370C and diminished at either lower or higher temperatures (Fig. 1) . 370C was used as the standard temperature for examining all other variables.
The concentration of gelatin in the standard buffered medium was varied between 0 and 3.0 g/100 ml. Maximal migration (Fig. 2 ) occurred between gelatin concentrations of 0.5 and 1.0 g/100 ml. All subsequent studies utilized 0.5 g/100 ml gelatin.
1 Abbreviations used in this paper: HPF, high-power fields; ID5o, dose required for 50% inhibition of migration. pH. In order to provide a broader buffering range Tris (hydroxymethyl) aminomethane (0.005 M) and acetic acid (0.005 M) were added to standard medium without NaCl. The pH was adjusted to levels between 4.0 and 11.0 with 0.1 M NaOH or 0.1 M HCl, followed by adjustment of the conductivity with 3.0 M NaCl to that of the standard buffer (12.6 mS at 220C). pH and conductivity were recorded after the platelets were suspended in the buffers. A peak of maximal migration was observed between pH 5.0 and 6.5 with a plateau being noted between 6.5 and 8.5; migration was not detected at pH less than 4.5 or greater than 10.0 (Fig. 3) .
Calcium, magnesium, and potassium. Because the platelet suspensions in the standard buffered medium contain no added Mg"+ or Ca", the concentration re- [GELAT/kiN, g//OOml FIGURE 2 Influence of gelatin concentration on the random migration of human platelets. Each related reduction in migration with 59±12% (mean± SD) inhibition at 10-7 M in 10 experiments (P <0.01).
Platelets were not visibly aggregated on the upper surface of the filters at concentrations of epinephrine as high as 104 M. To determine whether the action of epinephrine was mediated by the a or P receptor, the ability of equimolar amounts of phentolamine, an a-blocker, or propranolol, a A9-blocker, to interfere with this effect was studied. The inhibiti~on of migration by 10-7 M epinephrine was reversed by equimolar propranolol but not by phentolamine (Fig. 6 ). Pr~opranolol and phentolamine alone had no effect on migration. Isoproterenol, a pure fl-agonist, was nearly as active on a molar basis (IDS-~10-7 M) as epinephrine in terms of inhibiting migration; while phenylephrine, a pure a-agonist, had no effect at concentrations up to 104 M.
Because adrenergic and cholinergic agents often have opposing actions on biologic systems, the effect of the cholinomimetic agent carbachol on migration was determined. Carbachol caused an increase in platelet migrati~on over a broad concentration range (104 M-10-1 M) with a maximum enhancement of 55±27% (mean± § SD) increase at 10-9 M in four experiments (P < 0.05).
Prostaglandins and inhibitors of prostaglandin synthesis. Indomethacin, an agent known to inhibit platelet prostaglandin synthetase (7), produced a dose-related inhibition of migration at concentrations greater than 108 M (Fig. 7) with 53±17% (mean±SD) inhibition at 104 M in seven experiments (P < 0.01).
On the presumpti~on that the effect of indomethacin was mediated by changes in the availability of endogenous prostaglandins, the effect of exogenous prostaglandins PGE1, PGE2, and PGF~a was investigated (Fig. 8 ).
PGE1 caused a dose-related enhancement of migration which was maximal by 2.8 X< 10-7 M and fell to a lesser value at concentrations of 1. (Fig. 1) , required metabolic integrity of the platelets (Fig. 5) , and was not observed if the platelets had been prefixed in formalin. The suppression of migration by an adrenergic agent (Fig. 6 ) acting through a f receptor and the enhancement achieved with a cholinomimetic agent or certain prostaglandins (Fig.  8 ) support the view that movement is an active process modulated by specific pharmacologic agents. Platelet movement as assessed by egress from capillary tubes has also been considered an active process based upon recognition of a temperature optimum of 30-370C, inhibition by cytochalasin B, and chemotactic responsiveness to stimuli (8) (9) (10) . Studies of leukocyte migration have also demonstrated that movement from capillary tubes is an active migration but is more dependent on surface adherence and more resistant to metabolic inhibitors than migration in Boyden chambers (11 ) .
Because the platelet is extremely susceptible to aggregation the conditions for collection and handling as well as migration were selected to minimize such a possibility. Calcium ions, which are essential for the aggregation phenomenon, were not added to the migration buffer and were chelated during platelet harvesting by the addition to blood of sufficient sodium citrate anticoagulant to achieve final concentration of 3 X 10' M and pH 6.8. In addition, aggregation occurs most readily at pH above 7.2 (12) while the migration was most striking at pH 5.0-6.5 (Fig. 3) . That aggregation was in fact difficult to achieve under the experimental conditions for migration was supported by the failure to recognize aggregates on the filters at the highest concentration studied of the aggregating agent epinephrine (Fig. 6) . On the other hand, the platelets did have the capacity to aggregate, as evidenced by the presence of aggregates on the upper surface of the stained micropore filter when the calcium-free buffer was constituted with 102 M calcium or Mg"+ (Fig. 4) ; aggregation was possibly due to residual thrombin in the platelet suspension.
Compared to previous studies utilizing purified suspensions of human neutrophilic or eosinophilic polymorphonuclear leukocytes and mononuclear leukocytes, random migration of purified human platelets required a 25-fold greater cell concentration and enumeration halfway through the filter in order to achieve counts comparable to those found on the underside of the filter in leukocyte random migration. The pore size of 8 Am required for platelet migration is also utilized in studies of mononuclear leukocytes and basophils (13, 14) while the retarding effect of a 3 Am pore size is essential to the quantitation of eosinophilic and neutrophilic polymorphonuclear leukocytes. The finding of an optimal protein concentration (Fig. 2) for platelet migration is reminiscent of the protein requirements for migration of various leukocyte populations (15) and is consistent with the interpretation that low protein concentration impeded the process by allowing excessive surface adherence, while a high concentration prevented the degree of adherence required for progressive movement. Random migration of platelets, like that of polymorphonuclear leukocytes (16) , is suppressed by 2-iodoacetamide and 6-aminonicotinamide (Fig. 5) , agents which suppress glycolysis and the hexose monophosphate shunt, respectively. One apparent difference between the inherent requirements for spontaneous migration of human platelets as compared to rabbit neutrophilic leukocytes is that platelet migration is optimal in the absence of added magnesium and calcium (Fig.  4) , while leukocyte migration is reduced by low divalent cation concentration (17) . The inhibition of platelet migration by divalent cations can be attributed, however, to the aggregation of platelets by thrombin contaminating the suspension of platelets. It should be noted in considering any of the differences in the migration characteristics for platelets as compared to other cell types that the standard buffer is phosphate-buffered saline, pH 6.8, containing only added glucose and gelatin, whereas leukocyte migration is assessed in enriched buffers, e.g., Medium 199 (13, 14) . The basis for selecting a simple buffer was to minimize platelet aggregation and to facilitate determination of medium requirements.
The capacity of epinephrine and the prostaglandins to initiate and/or modulate platelet function has been noted in the platelet aggregation and release reactions (18, 19) while an effect of a cholinomimetic agent has not received comparable attention. Although the effect of epinephrine on the aggregation-release reaction is to initiate or facilitate through its a potential (18) , its action on random migration is inhibitory and dependent on interaction with a P receptor. This conclusion is based on the capacity of equimolar propranolol but not phentolamine to prevent epinephrine inhibition of random migration (Fig. 6 ) and on the finding that isoproterenol is nearly as active on a molar basis as epinephrine while phenylephrine is without effect. This recognition of a platelet function modulated by a P receptor is consistent with the report of 3-receptor-mediated platelet disaggregation (20) . Whether P-receptor-modulated platelet functions will prove a characteristic of other in vitro functions under comparable buffer conditions is not established. In this regard, Ahlquist observed that the relative predominance of a vs. 8 potential in a model system is influenced by the buffer characteristics (21) .
The opposing effect of adrenergic and cholinergic stimuli on biologic systems has more recently been appreciated in in vitro studies of effector cells of the inflammatory response such as tissue mast cells (22) , thymus-derived lymphocytes (23) , and polymorphonuclear leukocytes (24, 25) . P-Adrenergic stimuli suppressed the antigen-induced release of chemical mediators from lung fragments sensitized with IgE, the thymus lymphocyte-mediated destruction of allo-incompatible target cells, and the release of lysosomal enzymes by neutrophilic leukocytes during phagocytosis, while cholinergic stimuli enhanced each of these phenomena. The concentration of cholinomimetic agents active in each of these systems was several orders of magnitude less than those of the adrenergic stimuli. Hence, the demonstration of cholinergic enhancement of spontaneous platelet migration with a peak effect in the nanomolar range or less is entirely consistent with the findings involving other cells engaged in different functions. By analogy to the other systems (26) , the opposing action of P-adrenergic and cholinergic stimuli on platelet migration could relate to their influence on the intracellular levels of the cyclic nucleotides, cyclic AMP, and cyclic GMP, respectively.
The findings that PGE1 as well as high concentrations of PGE2 enhanced platelet migration (Fig. 8) are in contradistinction to their inhibitory action on the platelet aggregation-release reaction in a comparable dose (19) . The additional finding that indomethacin, an inhibitor of platelet prostaglandin synthetase (7), suppressed random migration (Fig. 7) suggests that a certain level of endogenous prostaglandin formation is essential to the migration process. This is supported by the capacity of indomethacin to prevent PGEL-mediated enhancement at the usual optimal dose, although a several fold increase in this dose will overcome the indomethacin effect. The influence of indomethacin on the expression of the prostaglandin enhancing action may mean that intermediates in prostaglandin biosynthesis act in concert with the end product. The capacity of indomethacin to diminish the effect of exogenous prostaglandins has also been observed in an in vitro system concerned with prostaglandin inhibition of antigeninduced mitogenesis (27) . Irrespective of whether intermediates in prostaglandin biosynthesis or the end products themselves are essential to migration and its augmentation by exogenous prostaglandins is the additional consideration of whether these effects involve a change in the ratio of cyclic nucleotides. A precise interpretation of the indomethacin or PGE1 effects on platelet function will require determination of the prostaglandins formed and the changes in the level of cyclic nucleotides in relation to pharmacologic and surface stimuli.
